Lauran Neergaard, The Associated Press

Lauran Neergaard

The Associated Press

Washington, DC, United States

Contact Lauran

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • San Jose Mercury News
  • KNWA News
  • FOX 29
  • The Associated Press
  • WLUK-TV FOX 11
  • KVUE News
  • FOX 5 Las Vegas
  • FOX 8 New Orleans
  • WBTV News
  • WSFA 12 News
  • FOX 12 Oregon KPTV
  • WAFB
  • KCRG
  • KCTV5 - Kansas City
  • KY3 News
  • KOTA Territory News
  • FOX19
  • Winnipeg Free Press
  • 13News Now
  • KATU News
  • CBS 8 San Diego
  • KSL
  • limanews
  • Fox5NY
  • L.A. Daily News
  • wdam
  • wave3news
  • Western Mass News
  • KFVS News
  • wilxTV
Past:
  • CBS46
  • NBC12 WWBT Richmond
  • WKYT
  • WIS News 10
  • nbc15_madison
  • KCBD NewsChannel11
  • WITN Headlines
  • PIX11
  • WTOL 11
  • WSYX ABC 6
  • and more…

Recent articles by Lauran:

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. → Read More

Virus found in pig heart used in human transplant

Researchers trying to learn what killed the first person to receive a heart transplant from a pig have discovered the organ harbored an animal virus but cannot yet say if it played any role in the man’s death. A Maryland man, 57-year-old David Bennett Sr., died in March, two months after the groundbreaking experimental transplant. […] → Read More

J&J COVID-19 vaccine distribution restricted due to blood clot risk, FDA says

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. → Read More

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. → Read More

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U. S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U. S. authorities for months have recommended that Americans get… → Read More

FDA places new restriction on Johnson & Johnson COVID-19 vaccine

The FDA said it decided to restrict Johnson & Johnson's COVID-19 vaccine after taking another look at data on the risk of life-threatening blood clots. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID-19 vaccine for littlest kids

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect babies, toddlers and preschoolers -- albeit not as effectively during the omicron surge as earlier in the pandemic. → Read More

Moderna seeks to be 1st with COVID shots for littlest kids

Moderna is seeking to be the first to offer COVID-19 vaccine for the youngest American children, as it asked the Food and Drug Administration Thursday to clear low-dose shots for babies, toddlers and preschoolers. → Read More

Moderna seeks to be 1st with COVID shots for littlest kids

Moderna's data, submitted to the FDA Thursday, is aimed at protecting the 18 million children unable to get the vaccine currently because of their age. → Read More